No Picture
News

Los Angeles Court Rejects Patrick Soon-Shiong’s Attempt to Avoid Sorrento Litigation Allowing Arbitration Case to Move Forward

SAN DIEGO, Oct. 15, 2019 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”) announced today that a Los Angeles Superior Court judge has rejected Patrick Soon-Shiong’s attempt to allow him and his company, NantPharma, to avoid … […]

No Picture
News

The $102B club: The top 15 R&D spenders in the global biopharma business — 2019 edition

Roche: The pharma giant delivered the blockbusters it had to have, here’s the second wave
AbbVie: A Phase III derailment costs AbbVie, but a big buyout and recent successes at the FDA help salve the wound
Merck: Can a single drug be too successful? An… […]

No Picture
News

Denovo Biopharma Receives FDA’s Permission to Proceed with a Biomarker-Guided Phase 2b Clinical Trial with DB102 (Enzastaurin) In First-Line Treatment of Glioblastoma (GBM)

SAN DIEGO, Oct. 15, 2019 /PRNewswire/ — Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced FDA’s approval to initiate Denovo’s Phase 2b clinical study of DB102 in patients with newly-diag… […]